Multiple system atrophy (MSA) is a neurodegenerative disorder with limited treatment options. However, recent research has yielded encouraging discoveries into new therapeutic approaches. Current focus centers on addressing the underlying mechanisms of MSA. One strategy under investigation involves pharmacological interventions to influence the ac